Last updated on December 2006

Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Schizophrenia
  • Age: Between 18 - 65 Years
  • Gender: Male or Female
  • Other:
    schizophrenia all types
    18>

You may not be eligible for this study if the following are true:

  • uti
    >65
    non organic state
    no depression treatment

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.